Sound Pharmaceuticals (SPI) is a privately held biopharmaceutical
company in Seattle, WA. Our goal is to develop prescription drugs
that will enable doctors and patients to prevent and treat hearing
loss, a disease that affects over 30 to 40 million Americans. Estimates
from the NIH and the CDC place the total annual costs of hearing
loss at approximately $50 billion per year in the U.S. alone.
Currently, there are no FDA approved drugs that protect or restore your hearing
from noise damage, ototoxic drugs or aging.